LumiraDx Investor Presentation Deck

125 100 75 50 25 0 Our Platform and Tests Target All Segments of the Global IVD(1) Market 12 POC Professional Testing lumiraDx™ LumiraDx Targets the Global IVD Market ($B) 64 Central Lab 28 COVID (1) "IVD" mea In Vitro Diagnostics. Source: Industry reports, companyestimates. 13 Self Testing Copyright © 2022 LumiraDx Ltd. All Rights Reserved. Worldwide 117 Total Diagnostic Market is Supported by Numerous Trends Increasing focus on early prevention and diagnostic testing Effort to improve health outcomes for patients, and cost effectiveness for healthcare providers and payers Ageing population in developed market ✓ Increase in disease prevalence Rise of Precision Medicine

View entire presentation